Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06933472 |
| Consolidated Lead Sponsor | Alebund Pharmaceuticals |
| Therapeutic Condition Cohort | Gastroenterology, Hepatology, and Renal |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 264 participants (ESTIMATED) |
| Registered Start Date | 2025-06-13 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University First Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Xiamen University | Xiamen, China | Open Hospital Dossier -> |
| Henan Provincial People's Hospital | Zhengzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.